1. Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
   Wanjun Lin et al, 2017, Scientific Reports CrossRef
2. The pharmacokinetics and anti-inflammatory effects of chelerythrine solid dispersions in vivo
   Weifeng Li et al, 2017, Journal of Drug Delivery Science and Technology CrossRef
3. Semisynthesis of alkaloids
   Sasadhar Majhi et al, 2024, Semisynthesis of Bioactive Compounds and their Biological Activities CrossRef
4. Chelerythrine chloride inhibits the progression of colorectal cancer by targeting cancer‐associated fibroblasts through intervention with WNT10B/β‐catenin and TGFβ2/Smad2/3 axis
   Dan Liang et al, 2023, Phytotherapy Research CrossRef
5. Synthetic and Naturally Occurring Heterocyclic Anticancer Compounds with Multiple Biological Targets
   Richard Kwamla Amewu et al, 2021, Molecules CrossRef
6. Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine
   Nianzhi Chen et al, 2022, Frontiers in Pharmacology CrossRef
7. Berberine as Source of Antiproliferative Hybrid Compounds: In Vitro Antiproliferative Activity and Quantitative Structure-activity Relationship
   Mario A. Leyva-Peralta et al, 2019, Anti-Cancer Agents in Medicinal Chemistry CrossRef
8. Orexin-A Protects Human Neuroblastoma SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Neurotoxicity: Involvement of PKC and PI3K Signaling Pathways
   Hamzeh Pasban-Aliabadi et al, 2017, Rejuvenation Research CrossRef
9. Antitumor Effects of Chelerythrine: A Literature Review
   Kai Kang et al, 2022, Natural Product Communications CrossRef
10. Alkaloids for cancer prevention and therapy: Current progress and future perspectives
    Arijit Mondal et al, 2019, European Journal of Pharmacology CrossRef
11. Chelerythrine down regulates expression of VEGFA, BCL2 and KRAS by arresting G-Quadruplex structures at their promoter regions
    Jagannath Jana et al, 2017, Scientific Reports CrossRef
12. Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their Structural Diversity and Mechanism of Action
    Afshin Zarghi et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
13. Chelerythrine ameliorates rheumatoid arthritis by modulating the AMPK/mTOR/ULK-1 signaling pathway
    Jun Cai et al, 2022, Phytomedicine CrossRef
14. Chelerythrine Attenuates Renal Ischemia/ Reperfusion-induced Myocardial Injury by Activating CSE/H2S via PKC/NF-κB Pathway in Diabetic Rats
    Bo Hu et al, 2017, Kidney and Blood Pressure Research CrossRef
15. Chelerythrine Chloride Downregulates β-Catenin and Inhibits Stem Cell Properties of Non-Small Cell Lung Carcinoma
    Win Sen Heng et al, 2020, Molecules CrossRef
16. Pterostilbene Inhibits Human Renal Cell Carcinoma Cells Growth and Induces DNA Damage
    Yuwan Zhao et al, 2020, Biological and Pharmaceutical Bulletin CrossRef
17. Modulation of Multiple Signaling Pathways of the Plant-Derived Natural Products in Cancer
    Li-rui Sun et al, 2019, Frontiers in Oncology CrossRef
18. An Update of the Sanguinarine and Benzophenanthridine Alkaloids’ Biosynthesis and Their Applications
    José Ignacio Laines-Hidalgo et al, 2022, Molecules CrossRef
19. Developmental toxicity induced by chelerythrine in zebrafish embryos via activating oxidative stress and apoptosis pathways
    Yuxin Shi et al, 2023, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology CrossRef
20. The inhibition of chloride intracellular channel 1 enhances Ca2+ and reactive oxygen species signaling in A549 human lung cancer cells
    Jae-Rin Lee et al, 2019, Experimental & Molecular Medicine CrossRef
21. Insights into the antineoplastic mechanism of Chelidonium majus via systems pharmacology approach
    Xinzhe Xiao et al, 2019, Quantitative Biology CrossRef
22. The Anticancer Effect of Natural Plant Alkaloid Isoquinolines
    Dahye Yun et al, 2021, International Journal of Molecular Sciences CrossRef
23. Chelerythrine, a novel small molecule targeting IL-2, inhibits melanoma progression by blocking the interaction between IL-2 and its receptor
    Okki Cho et al, 2023, Life Sciences CrossRef